1.
Eskiizmir G, Çalıbaşı G, Uysal T, Ellidokuz H, Baskın Y. Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study. ENTU [Internet]. 2016 Feb. 1 [cited 2025 Apr. 4];6(3). Available from: https://ojs.ukscip.com/index.php/ENTU/article/view/642